OPKO Health, Inc. Securities Fraud Class Action

VIEW COMPLAINT

Please complete this form relating to your transactions for OPKO Health, Inc. (Nasdaq: OPK) securities from September 26, 2013 through September 7, 2018, both dates inclusive (the "Class Period").

You may also contact Jon Naji, Esq. at (484) 270-1453; or you may submit your information via email at info@ktmc.com, or you may click here to print a PDF of this form.

Information Sheet

* Denotes required field

First Name *

Last Name *

Email *

Country

City

State\Province

Zip\Postal Code

Country Prefix

Phone Number

Phone Type

Purchase(s)

+ Additional Purchases

Sale(s)

+ Additional Sales

Date

# of Shares

Price per Share

Date

Principal Amount

Amount Paid

Series or CUSIP

Date

# of Contracts

Price per Contract

Exercise Price

Expiration Date

Did you purchase shares of OPKO Health, Inc. (2018) prior to the Class Period?

Yes

Are you a current or former employee of OPKO Health, Inc. (2018)?

Yes

The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.

I agree to the KTMC
disclaimer

Yes

I would like to receive
new case alerts by email

Yes

Submit Your Information

COMPANY	OPKO Health, Inc.
COURT	United States District Court for the Southern District of Florida
CASE NUMBER	18-cv-23786
JUDGE	The Hon. Jose E. Martinez
CLASS PERIOD	September 26, 2013 - September 7, 2018
SECURITY TYPE	Common Stock

Case Background:

On September 14, 2018, the initial complaint in this securities class action was filed against OPKO Health, Inc. (“OPKO” or the “Company”), and certain of OPKO’s directors and officers, asserting violations of sections 10(b) and 20(a) of the Securities Exchange Act.

The complaint alleged that the defendants made false and/or misleading statements and/or failed to disclose that: (1) OPKO and its Chairman and Chief Executive Officer were engaged in a pump-and-dump scheme with several other individuals and companies in their investments in several penny stocks; (2) this illicit scheme would result in governmental scrutiny including from the SEC; and (3) as a result, the defendants’ statements about OPKO’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

This securities class action lawsuit was brought on behalf of all persons or entities that purchased or otherwise acquired OPKO common stock during the period from September 26, 2013 through September 7, 2018, inclusive.

Current Status of Case:

On May 29, 2020, the parties informed the Court that they had reached a settlement in principle to settle this action for $16,500,000. On June 29, 2020, the parties entered into a Stipulation and Agreement of Settlement. The Court Preliminarily Approved the Settlement on September 4, 2020. On April 28, 2021, the Court issued an Order granting Final Approval of Settlement and entered Final Judgment on April 29, 2021. This action has concluded.

You may find additional information regarding the terms of the settlement and claim filing process at https://www.opkohealthsecuritieslitigation.com, or by calling JND Legal Administration at 888-383-0345.

If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; or via e-mail at info@ktmc.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.